Micot Pharma-B (02335.HK) Launches IPO: Max Offer Price at HK$21.0, Entry Fee Around HK$4,242 per Lot

NewTimesSpace(newtimespace.com) reports: Shaanxi Micot Pharmaceutical Technology Co., Ltd. ("Micot") announced on June 15, 2026, the launch of its global offering. The company will offer 58,054,400 H shares globally, comprising 5,805,600 H shares for the Hong Kong public offering and 52,248,800 H shares for the international offering. The maximum offer price is HK$21.0 per H share, with an expected minimum of HK$18.2 per share. The stock code is 2335. Shares will be traded in board lots of 200 H shares each. Based on the maximum offer price, the entry fee for one board lot is approximately HK$4,242.36, inclusive of a 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% AFRC transaction levy, and 0.00565% Stock Exchange trading fee.

According to the announcement, CCB International Capital Limited serves as the stabilizing manager, while CCB International and CMS International act as joint sponsors, overall coordinators, sponsors兼overall coordinators, joint global coordinators, joint bookrunners, and joint lead managers. The Hong Kong public offering commences at 9:00 a.m. on Monday, June 15, 2026. The deadline for completing electronic applications via the HK eIPO White Form Service is 11:30 a.m. on Thursday, June 18, 2026, and the deadline for submitting electronic application instructions to HKSCC is 12:00 noon on the same day. The final offer price, application levels, and allotment basis are expected to be announced on Tuesday, June 23, 2026, with H shares expected to commence trading on the Hong Kong Stock Exchange at 9:00 a.m. on Wednesday, June 24, 2026.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.